Topic

Oxlumo (lumasiran)

A collection of 16 issues

If Oxlumo (Lumasiran) Isn't Approved by UnitedHealthcare in Pennsylvania: Formulary Alternatives & Exception Paths

Answer Box: Your Next Steps When UnitedHealthcare Denies Oxlumo If UnitedHealthcare denied Oxlumo (lumasiran) for primary hyperoxaluria type 1 (PH1) in Pennsylvania, you have three main paths: try formulary alternatives like Rivfloza (nedosiran) or high-dose vitamin B6, request a formulary exception with specialist documentation, or appeal the denial through UnitedHealthcare&
5 min read

Renewing Oxlumo (lumasiran) Approval with UnitedHealthcare in Ohio: Timeline, Documentation & What to Prepare

Answer Box: Renewing Oxlumo (lumasiran) with UnitedHealthcare in Ohio UnitedHealthcare requires annual renewal for Oxlumo (lumasiran) with proof of at least 30% reduction in urinary oxalate levels from baseline. Start renewal 60-90 days before expiration. Submit updated lab results, clinical notes showing continued benefit, and specialist documentation through the UnitedHealthcare
5 min read

How Long Does It Take to Get Oxlumo (Lumasiran) Approved by Cigna in New Jersey? Complete Timeline Guide

Answer Box: Getting Oxlumo (Lumasiran) Approved by Cigna in New Jersey Timeline: Cigna typically reviews Oxlumo (lumasiran) prior authorization requests within 1-3 business days through Express Scripts. First step: Have your nephrologist or urologist submit genetic confirmation of PH1 (AGXT gene mutations), baseline urinary oxalate levels, and clinical documentation. If
6 min read